Inhibition of CD146 attenuates retinal neovascularization via vascular endothelial growth factor receptor 2 signalling pathway in proliferative diabetic retinopathy.
Jianqiang LinKaixuan CuiYue XuXiaoyu TangYuxun ShiXi LuBoyu YangQingjing HeShanshan YuXiaoling LiangPublished in: Acta ophthalmologica (2021)
Our results indicated that CD146 was involved in the development of retinal neovascularization via VEGFR2 pathway. Anti-CD146 may be an innovative or adjuvant therapy, which provides a new direction for the treatment of PDR and other ocular neovascular diseases.